Please login to the form below

Not currently logged in
Email:
Password:

Sue Neilen moves to Virgo Health from Langland

She becomes head of communications

Virgo Health Sue NeilenRichmond-based Virgo Health has appointed Sue Neilen as head of communications.

Neilen brings corporate communications strategy and reputation management expertise to the role, having moved to the agency from specialist health advertising agency Langland where she recently served as head of corporate communications.

Prior to this Neilen was a copywriter for Saatchi & Saatchi in Geneva, Switzerland, working with clients including Merck, Novartis, The Red Cross and the World Health Organization.

Ondine Whittington, managing director of Virgo Health, said: “We are thrilled to have Sue on board as her broad expertise and experience will be invaluable to our clients.”

Neilen said: “Virgo has a mighty reputation as an agency that puts people at its heart where they be clients, patients or employees.

“I'm looking forward to developing the diverse work of the communications division, helping our clients build their corporate and employer reputations while navigating industry and business challenges.”

15th June 2016

From: Marketing

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical education website. Support...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...